Michael S. Maddux
- Co-authors
- Raymond PollakSteven L. BarriereMartin F. MozesM MoránCarl B. WallemarkBeverley L. KetelOlga JonassonMark S. Paller
- Topics
- Renal Transplantation Outcomes and Treatments (8 papers)Antibiotics Pharmacokinetics and Efficacy (6 papers)Drug-Induced Adverse Reactions (4 papers)
- Partner nations
- United States
In The Last Decade
Michael S. Maddux
26 papers receiving 484 citations
Peers
Comparison fields: 5 of 93
- Surgery 153
- Transplantation 109
- Infectious Diseases 91
- Pharmacology 89
- Epidemiology 88
Countries citing papers authored by Michael S. Maddux
This map shows the geographic impact of Michael S. Maddux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Maddux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Maddux more than expected).
Fields of papers citing papers by Michael S. Maddux
This network shows the impact of papers produced by Michael S. Maddux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Maddux. The network helps show where Michael S. Maddux may publish in the future.
Co-authorship network of co-authors of Michael S. Maddux
This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Maddux. A scholar is included among the top collaborators of Michael S. Maddux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Maddux. Michael S. Maddux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 3 | |
| 3 | 3 | |
| 4 | 10 | |
| 5 | 2 | |
| 6 | 50 | |
| 7 | 17 | |
| 8 | 12 | |
| 9 | 4 | |
| 10 | 8 | |
| 11 | Utility of an in vitro immunoassay to guide immunosuppressive therapy. | 7 |
| 12 | 114 | |
| 13 | 22 | |
| 14 | Low-dose oral acyclovir for prevention of herpes simplex virus infection during OKT3 therapy. | 11 |
| 15 | Effective prophylaxis of early post-transplant urinary tract infections (UTI) in the cyclosporine (CSA) era. | 10 |
| 16 | Delayed graft function following cadaver renal transplantation in the cyclosporine era: analysis of acute rejection and graft survival. | 19 |
| 17 | Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejection. | 4 |
| 18 | Optimizing cyclosporine use in pediatric patients by measuring pretransplant blood levels. | 4 |
| 19 | A significant difference in cyclosporine blood and plasma concentrations with heparin or EDTA anticoagulant. | 3 |
| 20 | 89 |
About Michael S. Maddux
Michael S. Maddux is a scholar working on Transplantation, Applied Microbiology and Biotechnology and Pharmacology, having authored 26 papers that have together received 529 indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (8 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Drug-Induced Adverse Reactions (4 papers). The work is most often cited by research in Transplantation (109 citations), Pharmacology (89 citations) and Infectious Diseases (91 citations). Michael S. Maddux has collaborated with scholars based in United States. Frequent co-authors include Raymond Pollak, Steven L. Barriere, Martin F. Mozes, M Morán, Carl B. Wallemark, Beverley L. Ketel, Olga Jonasson, Mark S. Paller, Scott A. Gruber and P. Jan Geiseler. Their work appears in journals such as New England Journal of Medicine, CHEST Journal and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.